| Boca General & Family Medicine Pa | |
|
1500 Nw 10th Ave Suite 101 Boca Raton FL 33486-1312 | |
| (561) 391-2878 | |
| (561) 391-3112 |
| Full Name | Boca General & Family Medicine Pa |
|---|---|
| Speciality | Family Medicine |
| Location | 1500 Nw 10th Ave, Boca Raton, Florida |
| Authorized Official Name and Position | William Lee Rowland (OWNER) |
| Authorized Official Contact | 5613912787 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Boca General & Family Medicine Pa 1500 Nw 10th Ave Suite 101 Boca Raton FL 33486-1312 Ph: (561) 391-2878 | Boca General & Family Medicine Pa 1500 Nw 10th Ave Suite 101 Boca Raton FL 33486-1312 Ph: (561) 391-2878 |
| NPI Number | 1073724191 |
|---|---|
| Provider Enumeration Date | 05/24/2007 |
| Last Update Date | 09/11/2007 |
| Medicare PECOS PAC ID | 6507956828 |
|---|---|
| Medicare Enrollment ID | O20071226000178 |
News Archive
A research team has discovered that abnormal vision in childhood can affect the development of higher-level brain areas responsible for things such as attention.
Further strengthening its broad line of neurovascular products to treat unruptured brain aneurysms, Covidien plc announced the European launch of its Pipeline™ Flex embolization device at the annual Live Interventional Neuroradiology & Neurosurgery Course (LINNC), held in Paris June 23-25. This next-generation flow diversion device received CE Mark earlier this year.
Discovery Laboratories, Inc., reports preliminary results from its Phase 2 clinical trial of Surfaxin® in children with Acute Respiratory Failure (ARF), a critical condition often caused in children by severe respiratory infections. The objective of the study was to evaluate the safety and tolerability of intratracheal administration of Surfaxin and to assess whether Surfaxin treatment could decrease the duration of mechanical ventilation in children with ARF.
Research!America Chair John Edward Porter today called on elected officials to make a stronger investment in medical research in the new year to improve the health of Americans, maintain the nation's global competitiveness and boost the economy.
› Verified 5 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073724191 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | ME#60947 (Florida) | Primary |
| Provider Name | William L Rowland |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1639270200 PECOS PAC ID: 5294825675 Enrollment ID: I20071221000468 |
News Archive
A research team has discovered that abnormal vision in childhood can affect the development of higher-level brain areas responsible for things such as attention.
Further strengthening its broad line of neurovascular products to treat unruptured brain aneurysms, Covidien plc announced the European launch of its Pipeline™ Flex embolization device at the annual Live Interventional Neuroradiology & Neurosurgery Course (LINNC), held in Paris June 23-25. This next-generation flow diversion device received CE Mark earlier this year.
Discovery Laboratories, Inc., reports preliminary results from its Phase 2 clinical trial of Surfaxin® in children with Acute Respiratory Failure (ARF), a critical condition often caused in children by severe respiratory infections. The objective of the study was to evaluate the safety and tolerability of intratracheal administration of Surfaxin and to assess whether Surfaxin treatment could decrease the duration of mechanical ventilation in children with ARF.
Research!America Chair John Edward Porter today called on elected officials to make a stronger investment in medical research in the new year to improve the health of Americans, maintain the nation's global competitiveness and boost the economy.
› Verified 5 days ago
| Provider Name | Michelle K Feffer |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1740705607 PECOS PAC ID: 2769743368 Enrollment ID: I20180222001148 |
News Archive
A research team has discovered that abnormal vision in childhood can affect the development of higher-level brain areas responsible for things such as attention.
Further strengthening its broad line of neurovascular products to treat unruptured brain aneurysms, Covidien plc announced the European launch of its Pipeline™ Flex embolization device at the annual Live Interventional Neuroradiology & Neurosurgery Course (LINNC), held in Paris June 23-25. This next-generation flow diversion device received CE Mark earlier this year.
Discovery Laboratories, Inc., reports preliminary results from its Phase 2 clinical trial of Surfaxin® in children with Acute Respiratory Failure (ARF), a critical condition often caused in children by severe respiratory infections. The objective of the study was to evaluate the safety and tolerability of intratracheal administration of Surfaxin and to assess whether Surfaxin treatment could decrease the duration of mechanical ventilation in children with ARF.
Research!America Chair John Edward Porter today called on elected officials to make a stronger investment in medical research in the new year to improve the health of Americans, maintain the nation's global competitiveness and boost the economy.
› Verified 5 days ago
| Provider Name | Daniela Olivera-parente |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1114439726 PECOS PAC ID: 1658627351 Enrollment ID: I20211203000939 |
News Archive
A research team has discovered that abnormal vision in childhood can affect the development of higher-level brain areas responsible for things such as attention.
Further strengthening its broad line of neurovascular products to treat unruptured brain aneurysms, Covidien plc announced the European launch of its Pipeline™ Flex embolization device at the annual Live Interventional Neuroradiology & Neurosurgery Course (LINNC), held in Paris June 23-25. This next-generation flow diversion device received CE Mark earlier this year.
Discovery Laboratories, Inc., reports preliminary results from its Phase 2 clinical trial of Surfaxin® in children with Acute Respiratory Failure (ARF), a critical condition often caused in children by severe respiratory infections. The objective of the study was to evaluate the safety and tolerability of intratracheal administration of Surfaxin and to assess whether Surfaxin treatment could decrease the duration of mechanical ventilation in children with ARF.
Research!America Chair John Edward Porter today called on elected officials to make a stronger investment in medical research in the new year to improve the health of Americans, maintain the nation's global competitiveness and boost the economy.
› Verified 5 days ago
| Provider Name | Jessica Dianne Niles |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1770160756 PECOS PAC ID: 2466837711 Enrollment ID: I20220922001302 |
News Archive
A research team has discovered that abnormal vision in childhood can affect the development of higher-level brain areas responsible for things such as attention.
Further strengthening its broad line of neurovascular products to treat unruptured brain aneurysms, Covidien plc announced the European launch of its Pipeline™ Flex embolization device at the annual Live Interventional Neuroradiology & Neurosurgery Course (LINNC), held in Paris June 23-25. This next-generation flow diversion device received CE Mark earlier this year.
Discovery Laboratories, Inc., reports preliminary results from its Phase 2 clinical trial of Surfaxin® in children with Acute Respiratory Failure (ARF), a critical condition often caused in children by severe respiratory infections. The objective of the study was to evaluate the safety and tolerability of intratracheal administration of Surfaxin and to assess whether Surfaxin treatment could decrease the duration of mechanical ventilation in children with ARF.
Research!America Chair John Edward Porter today called on elected officials to make a stronger investment in medical research in the new year to improve the health of Americans, maintain the nation's global competitiveness and boost the economy.
› Verified 5 days ago
News Archive
A research team has discovered that abnormal vision in childhood can affect the development of higher-level brain areas responsible for things such as attention.
Further strengthening its broad line of neurovascular products to treat unruptured brain aneurysms, Covidien plc announced the European launch of its Pipeline™ Flex embolization device at the annual Live Interventional Neuroradiology & Neurosurgery Course (LINNC), held in Paris June 23-25. This next-generation flow diversion device received CE Mark earlier this year.
Discovery Laboratories, Inc., reports preliminary results from its Phase 2 clinical trial of Surfaxin® in children with Acute Respiratory Failure (ARF), a critical condition often caused in children by severe respiratory infections. The objective of the study was to evaluate the safety and tolerability of intratracheal administration of Surfaxin and to assess whether Surfaxin treatment could decrease the duration of mechanical ventilation in children with ARF.
Research!America Chair John Edward Porter today called on elected officials to make a stronger investment in medical research in the new year to improve the health of Americans, maintain the nation's global competitiveness and boost the economy.
› Verified 5 days ago
Boca Integrative Health Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 7100 W Camino Real, Ste. 207, Boca Raton, FL 33433 Phone: 561-391-2770 Fax: 561-391-2930 | |
Proactive Medical Solutions Pllc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 17808 Key Vista Way, Boca Raton, FL 33496 Phone: 646-456-4407 Fax: 888-254-2756 | |
Michelle Y Bruzzo Md Pa Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 1905 Clint Moore Rd, Suite 302, Boca Raton, FL 33496 Phone: 561-988-5387 Fax: 561-988-5388 | |
Gjorgji Trnovski Md Pa Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 1050 Nw 15th St, Suite 215a, Boca Raton, FL 33486 Phone: 561-955-1890 Fax: 561-392-8103 | |
Tamara Liss Md Pa Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 801 Meadows Rd, Suite 103, Boca Raton, FL 33486 Phone: 561-347-9044 Fax: 561-347-9043 | |
Daniel Ohara M D P A Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 660 Glades Rd, Suite # 380, Boca Raton, FL 33431 Phone: 561-393-1994 Fax: 561-393-2445 | |
Royal Family Medicine Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 3886 Candlewood Blvd, Boca Raton, FL 33487 Phone: 787-415-8405 |